Catabasis Pharmaceuticals announced it will present data on CAT-1004 at the XIV International Conference on Duchenne and Becker Muscular Dystrophy to be held in Rome, Italy, on Feb. 13-14. Joanne Donovan, chief medical officer of Catabasis, will talk about the drug, now in clinical testing, and the design of the MoveDMD…
News
Sarepta Therapeutics, a developer of RNA-targeted treatments, announced that the U.S. Food and Drug Administration (FDA) is extending by another three months its review of the company’s New Drug Application (NDA) for eteplirsen, a potential treatment for Duchenne muscular dystrophy (DMD) amenable to exon 51 skipping. A reason for the extension was…
Catabasis Pharmaceuticals and the Muscular Dystrophy Association (MDA) have announced a partnership that will support Part B of the MoveDMD clinical trial, currently evaluating the effectiveness and safety of Duchenne muscular dystrophy (DMD) treatment candidate CAT-1004 in children. CAT-1004, believed to be a disease modulator regardless of mutation, is…
In recognition that people with muscular dystrophy are living longer than even recently thought possible, the Muscular Dystrophy Association (MDA) has named a young man as its latest National Goodwill Ambassador — marking the first time in the program’s 64-year history that a child hasn’t been selected for that role.
Jiffy Lube International has raised more than $1 million dollars in a campaign to support the Muscular Dystrophy Association (MDA). The company holds more than 2,000 franchised oil change service centers and has partnered with MDA for the fourth year to support children and adults who suffer from muscular dystrophy,…
The Kessler Foundation and the New Jersey Institute of Technology (NJIT) will share a $5 million federal grant, titled Rehabilitation Engineering Research Center on Wearable Robots, to develop a wearable robotic exoskeleton for use in patients with Duchenne muscular dystrophy (DMD), as well as other applications for spinal cord injury and stroke.
More than a dozen children in the Tampa, Florida area with muscular dystrophy, Down’s syndrome, and other neuromuscular disorders will soon be getting new and specially adapted bicycles donated by the ACMG Foundation for Genetic and Genomic Medicine. The 17 young recipients are from the local chapter of the Muscular Dystrophy Association (MDA) and …
Advances in stem cell therapy using patients’ own cells with genetically modified dystrophin have been hampered by the large size of the dystrophin gene, which are difficult to pack into a delivery system. Now, scientists at University College London have managed to produce a gene construct much bigger than was…
Regenerative medicine is a branch of research that deals with the process of replacing, engineering or regenerating human cells, tissues, or organs to restore or establish normal function. But a major challenge in this field has been delivering treatments to control cellular behavior. One possible strategy to overcome this problem is to…
Comedian and actor Jerry Lewis, the longtime Muscular Dystrophy Association national chairman and host of the organization’s former Labor Day Telethon, is returning from his retired role with the groundbreaking charity that revolutionized public philanthropic giving in America. Lewis helped introduce MDA’s revitalized brand on Jan. 29, when the Chicago-based charity…
Recent Posts
- Bridgebio asks FDA to approve potential 1st treatment for LGMD2i
- I’m grateful for meaningful conversations with my adult children
- Early trial data support RNA therapies for two muscular dystrophy types
- Figuring out where to buy a lift chair for my FSHD symptoms was no small task
- Sarepta plans to seek full FDA approval of 2 Duchenne treatments